<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: The aim of this prospective study was to investigate predictors of deteriorating <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance in subjects of British extraction </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A total of 156 non-diabetic subjects (86 with a family history of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>) underwent a 75-g OGTT and anthropometric assessment at baseline and 5 years later </plain></SENT>
<SENT sid="2" pm="."><plain>Pancreatic beta cell function and whole-body insulin sensitivity were studied by model assessment </plain></SENT>
<SENT sid="3" pm="."><plain>Subjects were classified as progressors if <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance moved one or more steps from <z:mpath ids='MPATH_458'>normal</z:mpath>, impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> and <z:mp ids='MP_0002055'>diabetes</z:mp> over the follow-up period </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: At baseline, the progressors (n=22) had <z:mp ids='MP_0010024'>increased adiposity</z:mp> and a higher proportion of familial <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0001952'>abnormal glucose tolerance</z:hpo> than non-progressors </plain></SENT>
<SENT sid="5" pm="."><plain>Baseline pancreatic beta cell sensitivity to changes in <z:chebi fb="105" ids="17234">glucose</z:chebi> (p&lt;0.02) and whole-body insulin sensitivity (p&lt;0.0001) were decreased in the progressors </plain></SENT>
<SENT sid="6" pm="."><plain>Logistic regression revealed that baseline and follow-up changes in beta cell <z:chebi fb="105" ids="17234">glucose</z:chebi> sensitivity and insulin sensitivity, rather than the classical clinical predictors (<z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e>, familial <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:chebi fb="105" ids="17234">glucose</z:chebi> levels), were the key independent predictors of progression (explaining over 50% of the progression) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS/INTERPRETATION: Impaired pancreatic beta cell <z:chebi fb="105" ids="17234">glucose</z:chebi> sensing and whole-body insulin sensitivity predict progression to <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Strikingly, these pathophysiological changes override the importance of the clinical risk factors and highlight potential metabolic targets for prevention strategies </plain></SENT>
</text></document>